Edition:
United Kingdom

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

630.00SEK
4:28pm GMT
Change (% chg)

-8.00kr (-1.25%)
Prev Close
638.00kr
Open
638.00kr
Day's High
638.00kr
Day's Low
627.00kr
Volume
11,612
Avg. Vol
29,752
52-wk High
717.00kr
52-wk Low
355.00kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.58
Market Cap(Mil.): kr14,480.65
Shares Outstanding(Mil.): 21.71
Dividend: 2.60
Yield (%): 0.39

Financials

  Industry Sector
P/E (TTM): -- 32.16 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-William Demant fund raises stake in Vitrolife to 21.6 pct

* William Demants Og Hustru Ida Emilies Fond​ (Oticon fund) raises stake in Vitrolife AB to 21.6 percent

10 Nov 2017

BRIEF-Vitrolife Q3 core profit rises, like-for-like sales grow 20 pct​

* Q3 ‍sales amounted to SEK 246 (210) million, corresponding to an increase of 17 percent in SEK​

02 Nov 2017

BRIEF-Vitrolife Q2 EBITDA rises to SEK 112 mln

* Q2 operating income before depreciation and amortisation (EBITDA) amounted to SEK 112 (74) million

14 Jul 2017

Earnings vs. Estimates